↓ Skip to main content

Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials

Overview of attention for article published in Frontiers in oncology, February 2023
Altmetric Badge

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials
Published in
Frontiers in oncology, February 2023
DOI 10.3389/fonc.2023.1133828
Pubmed ID
Authors

Junjie Lu, Desheng Hu, Yan Zhang, Chen Ma, Lin Shen, Bo Shuai

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 24%
Unspecified 2 8%
Student > Bachelor 2 8%
Professor 1 4%
Student > Master 1 4%
Other 1 4%
Unknown 12 48%
Readers by discipline Count As %
Medicine and Dentistry 6 24%
Biochemistry, Genetics and Molecular Biology 3 12%
Unspecified 2 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Unknown 13 52%